Charles S. Berkman

2011 - Ligand Pharmaceuticals

In 2011, Charles S. Berkman earned a total compensation of $478.9K as Vice President and General Counsel at Ligand Pharmaceuticals, a 4% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$99,888
Option Awards$96,278
Salary$249,719
Stock Awards$30,150
Other$2,838
Total$478,873

Berkman received $249.7K in salary, accounting for 52% of the total pay in 2011.

Berkman also received $99.9K in non-equity incentive plan, $96.3K in option awards, $30.2K in stock awards and $2.8K in other compensation.

Rankings

In 2011, Charles S. Berkman's compensation ranked 8,193rd out of 10,747 executives tracked by ExecPay. In other words, Berkman earned more than 23.8% of executives.

ClassificationRankingPercentile
All
8,193
out of 10,747
24th
Division
Manufacturing
3,016
out of 3,960
24th
Major group
Chemicals And Allied Products
750
out of 1,033
27th
Industry group
Drugs
539
out of 781
31st
Industry
Pharmaceutical Preparations
417
out of 571
27th
Source: SEC filing on April 21, 2014.

Berkman's colleagues

We found three more compensation records of executives who worked with Charles S. Berkman at Ligand Pharmaceuticals in 2011.

2011

John Higgins

Ligand Pharmaceuticals

Chief Executive Officer

2011

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

2011

John Sharp

Ligand Pharmaceuticals

Chief Financial Officer

News

You may also like